logo
Why WeRide Inc. (WRD) Went Up On Tuesday

Why WeRide Inc. (WRD) Went Up On Tuesday

Yahoo4 days ago

We recently published a list of . In this article, we are going to take a look at where WeRide Inc. (NASDAQ:WRD) stands against other best-performing stocks.
WeRide Inc. jumped by 18.22 percent on Tuesday to end at $10.77 apiece following its official expansion into Saudi Arabia with the deployment of its autonomous driving vehicles into the said country.
In a statement, WeRide Inc. (NASDAQ:WRD) said it deployed robotaxis and robobus in Riyadh and AlUla as part of its preparation works for its upcoming robotaxi operations under the Uber app.
WeRide Inc. (NASDAQ:WRD) said it is set to launch on Uber over the next few months, with full commercial operations in late 2025.
Additionally, the expansion supports Saudi Arabia's Vision 2030 ambitions to build smart, sustainable cities by enhancing road safety, traffic management, and introducing innovative mobility solutions.
A pick-up and delivery truck speeding down a busy city street.
Earlier this month, WeRide Inc. (NASDAQ:WRD) fully launched driverless Robotaxi testing in Abu Dhabi—the first deployment of its kind in the region. It will also be extending its Robotaxi service coverage to Al Maryah and Al Reem Islands.
Overall, WRD ranks 3rd on our list of best-performing stocks. While we acknowledge the potential of WRD, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than WRD and that has 10,000x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Drug maker Indivior joins the flight from London share listings
Drug maker Indivior joins the flight from London share listings

Yahoo

time18 minutes ago

  • Yahoo

Drug maker Indivior joins the flight from London share listings

Drug maker Indivior has become the latest major UK listed company to scrap its London share trading. The pharmaceuticals company, which has its UK headquarters in Slough, said it planned to cancel its secondary listing in London. Indivior only moved its primary listing to Nasdaq last June and now wants to sever all share trading links with the City. The move comes just a year after Invidior's board said it planned to keep the London listing "for as long as it is considered to be in the best interests of Indivior and its shareholders as a whole." Reasons given for scrapping the London listing following a review include the fact that 80% of the company's revenue is generated in America; trading on Nasdaq accounts for approximately 75% of total volumes across both exchanges; more than 70% of the share are now held by investors located in the U.S; and the elimination of 'the cost and complexity of maintaining a secondary listing.' Another major factor is that the company's biggest selling drug Sublocade, a treatment for helping opioid addicts reduce their dependence, has its biggest market in the US. Last year Sublocade accounted for $756 million of the company's total $1.2 billion sales. Indivior was spun out of its former parent company, the consumer products giant Reckitt Benckizer in 2014 as a free standing London listed company. The Virginia based company's chair David Wheadon, said:"We are pleased to announce this key milestone for Indivior following our evaluation period. A single primary listing on Nasdaq best reflects the profile of Indivior's business. 'We appreciate the support received from shareholders for this initiative and look forward to capitalizing on the expected benefits of this move, including reductions in cost and complexity." London has suffered a major outflow of listed companies over recent years in a blow to the prestige of the City. A total of 88 firms delisted or transferred their primary listing from the London Stock Exchange last year, the highest number since the financial crisis of 2008, according to auditor EY. Only 18 companies came on to the London market last year as the vital flow of small and growing businesses raising capital by listing their shares on the London stock market dried up. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Here's how Uber's product chief uses AI at work — and one tool he's going to use next
Here's how Uber's product chief uses AI at work — and one tool he's going to use next

Yahoo

time18 minutes ago

  • Yahoo

Here's how Uber's product chief uses AI at work — and one tool he's going to use next

Uber's product chief said he uses AI to summarize lengthy reports and do research before launches. Sachin Kansal uses ChatGPT and Gemini to understand Uber's performance in overseas markets. He plans to add Google's NotebookLM to his AI suite. Uber's chief product officer has one AI tool on his to-do list. In an episode of "Lenny's Podcast" released on Sunday, Uber's product chief, Sachin Kansal, shared two ways he is using AI for his everyday tasks at the ride-hailing giant and how he plans to add NotebookLM to his AI suite. Kansal joined Uber eight years ago as its director of product management after working at cybersecurity and taxi startups. He became Uber's product chief last year. Kansal said he uses OpenAI's ChatGPT and Google's Gemini to summarize long reports. "Some of these reports, they're 50 to 100 pages long," he said. "I will never have the time to read them." He said he uses the chatbots to acquaint himself with what's happening and how riders are feeling in Uber's various markets, such as South Africa, Brazil, and Korea. The CPO said his second use case is treating AI like a research assistant, because some large language models now offer a deep research feature. Kansal gave a recent example of when his team was thinking about a new driver feature. He asked ChatGPT's deep research mode about what drivers may think of the add-on. "It's an amazing research assistant and it's absolutely a starting point for a brainstorm with my team with some really, really good ideas," the CPO said. In April, Uber's CEO, Dara Khosrowshahi, said that not enough of his 30,000-odd employees are using AI. He said learning to work with AI agents to code is "going to be an absolute necessity at Uber within a year." Uber did not immediately respond to a request for comment from Business Insider. On the podcast, Kansal also highlighted NotebookLM, Google Lab's research and note-taking tool, which is especially helpful for interacting with documents. He said he doesn't use the product yet, but wants to. "I know a lot of people who have started using it, and that is the next thing that I'm going to use," he said. "Just to be able to build an audio podcast based on a bunch of information that you can consume. I think that's awesome," he added. Kansal was referring to the "Audio Overview" feature, which summarizes uploaded content in the form of two AIs having a voice discussion. NotebookLM was launched in mid-2023 and has quickly become a must-have tool for researchers and AI enthusiasts. Andrej Karpathy, Tesla's former director of AI and OpenAI cofounder, is among those who have praised the tool and its podcast feature. "It's possible that NotebookLM podcast episode generation is touching on a whole new territory of highly compelling LLM product formats," he said in a September post on X. "Feels reminiscent of ChatGPT. Maybe I'm overreacting." Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Indivior to delist from London Stock Exchange, maintain Nasdaq listing
Indivior to delist from London Stock Exchange, maintain Nasdaq listing

Yahoo

time33 minutes ago

  • Yahoo

Indivior to delist from London Stock Exchange, maintain Nasdaq listing

(Reuters) -Pharma firm Indivior said on Monday it will cancel its secondary listing on the London Stock Exchange, effective July 25, maintaining its primary listing on the Nasdaq to reduce costs and better align with its U.S.-centric business. The company, known for its opioid addiction treatment, joins a growing number of companies delisting from London, as lower valuations and weak investor appetite continue to drive firms toward U.S. markets. Shares of Indivior, which floated in London in late 2014, have dropped more than 60% from record highs hit in June 2018. The company said over 80% of its revenue now comes from the U.S., with the Nasdaq accounting for about 75% of recent trading volumes. The delisting aims to streamline operations and reflect the company's strategic focus on the U.S. market, it said. Indivior moved its primary listing to the United States last year. The decision to delist from London comes just months after Indivior overhauled its management. Earlier this year, it appointed David Wheadon as chair and Joe Ciaffoni as CEO. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store